Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program.

Journal of genetic counseling - 1 Feb 2017

Bunnell A E, Garby C A, Pearson E J, Walker S A, Panos L E, Blum Joanne L

Abstract excerpt

Since the 2013 Supreme Court ruling on BRCA1/BRCA2 patenting, hereditary cancer gene panels now include BRCA1 and BRCA2, making these panels an option for first-tier testing. However, questions remain about the clinical utility and implications of these panels for medical management with inclusion of genes of unknown to moderate penetrance. To better understand how use of these panels affected our practice, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genes, Neoplasm

Share to Genetic Testing

Share to High-Throughput Nucleotide Sequencing

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 27276934
DOI: 10.1007/s10897-016-9985-2

Genes

BRCA2
BRCA1
ATM
CDH1
CHEK2
NBN
PALB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program.PMID 27276934Read ↗

Effects of Cancer Genetic Panel Testing on at-Risk Individuals.Semantic proximity Read ↗

Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test.Semantic proximity Read ↗

Identification of Patients at Elevated Cancer Risk through a Community-Based Genetic Testing Program.Semantic proximity Read ↗

Multigene Testing for Hereditary Cancer: When, Why, and How.Semantic proximity Read ↗

Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.Semantic proximity Read ↗

Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel.Semantic proximity Read ↗

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.Semantic proximity Read ↗

Development and Validation of a 34-Gene Inherited Cancer Predisposition Panel Using Next-Generation Sequencing.Semantic proximity Read ↗

Inherited Cancer in the Age of Next-Generation Sequencing.Semantic proximity Read ↗

Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.Semantic proximity Read ↗

Outcomes of large panel genetic evaluation of breast cancer patients in a community-based cancer institute.Semantic proximity Read ↗

The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.